The incidence of liver cancer in China is very high, because liver cancer is difficult to find in the early stage of the disease. Once the diagnosis is often in the middle and late stages, the optimal treatment time is often missed. The traditional treatment for liver cancer is surgery, radiotherapy and chemotherapy, etc. However, such treatment methods generally have a relatively high recurrence rate, and the survival rate of patients is relatively low. To prevent recurrence and metastasis of liver tumors, cell imunoterapija može se isprobati u ovom trenutku.
Due to the limitation of liver tumor size, growth location, and relationship with the position of large blood vessels and biliary tract, some patients with special small liver cancer, huge liver tumor, and middle-advanced liver cancer with multiple metastatic lesions often lose the opportunity for surgery.
However, for these patients, the expert’s approach is to first use argon-helium ultra-cold knife minimally invasive treatment, through physical freezing and thawing to destroy the cell structure of tumor tissue in a short period of time, promote tumor tissue necrosis and close tumor small blood vessels. At the same time, combined with interventional therapy, embolization of tumor large vessels and local high-concentration chemotherapy, the combination of the two therapies can inhibit the growth of liver stanice raka and eliminate tumor lesions in a short period of time.
In general, most of the primary karcinomi jetre are large undetectable liver cancers, which are accompanied by tumor thrombi in the internal and external portal vein system. The recurrence rate within one year after radiotherapy and chemotherapy is as high as 60%, and the 3-year survival rate is less than 30%. Therefore, the most important thing for liver cancer surgery is to prevent recurrence, but traditional radiotherapy and chemotherapy have large side effects, which can easily lead to liver cirrhosis and even liver function damage.
Relativno nova metoda liječenja - biološki stanični imunitet
(CIK stanice) imaju značajan učinak na uznapredovali karcinom jetre. Ova terapija može pomoći u čišćenju preostalih stanica raka u tijelu pacijenta, obnoviti imunološku funkciju pacijenta u prepoznavanju i ubijanju stanica raka te tako spriječiti i kontrolirati metastaze tumora.
CIK stanice su stanice ubojice izazvane citokinima, a to su mononuklearne stanice izolirane iz periferne krvi, koštane srži ili krvi pupkovine. Nakon određenog vremenskog razdoblja u laboratoriju, one se induciraju, razmnožavaju i zatim ponovno unose u pacijenta kako bi izravno ubile krv. Tumorske stanice u limfi također reguliraju i pojačavaju imunološku funkciju pacijenta.
Prema kliničkim statistikama, 9 pacijenata s rakom jetre u stadiju 4 podvrgnuto je više od 3 ciklusa stanične imunoterapije nakon operacije, što može bolje spriječiti ponovnu pojavu raka jetre nakon operacije. Prosječno vrijeme preživljenja nakon liječenja je 20 mjeseci, a stopa recidiva unutar 1 godine je samo 22.2%, a simptomi nelagode većine pacijenata su poboljšani
Gore navedeno jednostavno razumijevanje sprječavanja recidiva tumora jetre i metastaza, možete isprobati staničnu imunoterapiju, stanična imunoterapija je relativno nova metoda liječenja raka, kao što je biološka stanična imunoterapija, može pomoći pacijentima da uklone zaostale stanice raka u tijelu, osim imuniteta Terapija ima učinak identificiranja i ubijanja stanica raka, čime se dodatno sprječava širenje i metastaziranje tumora.
